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Résumé 
Objectifs  
La chirurgie pancréatique reste associée à une morbidité postopératoire importante. Les 
efforts sont concentrés la plupart du temps sur la diminution de cette morbidité, mais la 
détection précoce de patients à risque de complications pourrait être une autre stratégie 
valable. Un score simple de prédiction des complications après duodénopancréatectomie 
céphalique a récemment été publié par Braga et al. La présente étude a pour but de valider ce 
score et de discuter de ses possibles implications cliniques.  
Méthodes 
De 2000 à 2015, 245 patients ont bénéficié d’une duodénopancréatectomie céphalique dans 
notre service. Les complications postopératoires ont été recensées selon la classification de 
Dindo et Clavien. Le score de Braga se base sur quatre paramètres : le score ASA (American 
Society of Anesthesiologists), la texture du pancréas, le diamètre du canal de Wirsung (canal 
pancréatique principal) et les pertes sanguines intra-opératoires. Un score de risque global de 
0 à 15 peut être calculé pour chaque patient. La puissance de discrimination du score a été 
calculée en utilisant une courbe ROC (receiver operating characteristic). 
Résultats 
Des complications majeures sont apparues chez 31% des patients, alors que 17% des patients 
ont eu des complications majeures dans l’article de Braga. La texture du pancréas et les pertes 
sanguines étaient statistiquement significativement corrélées à une morbidité accrue. Les aires 
sous la courbe étaient respectivement de 0.95 et 0.99 pour les scores classés en quatre 
catégories de risques (de 0 à 3, 4 à 7, 8 à 11 et 12 à 15) et pour les scores individuels (de 0 à 
15).  
Conclusions 
Le score de Braga permet donc une bonne discrimination entre les complications mineures et 
majeures. Notre étude de validation suggère que ce score peut être utilisé comme un outil 
pronostique de complications majeures après duodénopancréatectomie céphalique. Les 
implications cliniques, c’est-à-dire si les stratégies de prise en charge postopératoire doivent 
être adaptées en fonction du risque individuel du patient, restent cependant à élucider. 
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Abstract 
Objectives  
Pancreatic surgery remains associated with important morbidity. Efforts are most commonly 
concentrated on decreasing postoperative morbidity, but early detection of patients at risk 
could be another valuable strategy. A simple prognostic score has recently been published. 
This study aimed to validate this score and discuss possible clinical implications. 
Methods 
From 2000 to 2012, 245 patients underwent pancreaticoduodenectomy. Complications were 
graded according to the Dindo-Clavien classification. The Braga score is based on American 
Society of Anesthesiologists score, pancreatic texture, Wirsung duct diameter, and blood loss. 
An overall risk score (from 0 to 15) can be calculated for each patient. Score discriminant 
power was calculated using a receiver operating characteristic curve. 
Results 
Major complications occurred in 31% of patients compared to 17% in Braga’s data. 
Pancreatic texture and blood loss were independently statistically significant for increased 
morbidity. The areas under curve were 0.95 and 0.99 for 4-risk categories and for individual 
scores, respectively.  
Conclusions 
The Braga score discriminates well between minor and major complications. Our validation 
suggests that it can be used as prognostic tool for major complications after 
pancreaticoduodenectomy. The clinical implications, i.e., whether postoperative treatment 
strategies should be adapted according to the patient’s individual risk, remain to be 
elucidated. 
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Keywords: pancreatic surgery - prognosis after pancreaticoduodenectomy - complication of 
pancreatic surgery - risk score - external validation. 
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Introduction 
A better perioperative management significantly decreased mortality rates after pancreas 
surgery during recent two decades, mainly in high-volume centers (1, 2). However, morbidity 
remains stuck at a high level, and reported complication rates are ranging up to 35-50% (3, 4). 
Until recently, the surgical community underestimated that, in particular, severe 
complications negatively impact on postoperative outcomes, i.e., long-term survival, quality 
of life, and costs (5). Regarding also the facts that pancreatic cancer incidence is increasing in 
many Western countries, patient populations are getting older, and not to forget, potent 
oncological treatments become increasingly available, makes it of the utmost importance to 
effectively decrease postoperative morbidity (6). 
As a first step, internationally accepted classification systems taking into account the 
occurrence as well as the severity of complications have been developed to assess 
complications after pancreas resection in a comparable and standardized manner (4, 7–9). 
Then, most efforts have been concentrated on decreasing complications once they have 
occurred postoperatively. While such an approach may work well for minor complications, 
anticipation of potentially severe complications and early detection of patients at risk 
represent another valuable strategy, which is worthwhile to further explore. It is a common 
clinical observation that complications in an individual patient do occur if too many risk 
factors are present at the same time (8, 10, 11). Some risk factors are already preoperatively 
present, such as malnutrition, cardiovascular disease, or smoking, while others become overt 
intraoperatively, such as soft pancreatic texture, small pancreatic duct diameter, or adverse 
events as bleeding.  
Ideally, a simple prognostic score taking into account some preoperative and intraoperative 
features would allow identifying patients at risk for postoperative complications. Such 
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patients could be treated differently and followed more closely during the postoperative 
course. Moreover, modifiable risk factors, e.g., malnutrition, could be treated already 
preoperatively.  
Recently, such a prognostic score has been published by Braga et al. (12). Briefly, American 
Society of Anesthesiologists (ASA) classification, pancreatic texture, main pancreatic duct 
diameter, and intraoperative blood loss are used to calculate a score indicating the risk of 
developing postoperative complications. The aim of this current study was to validate this 
prognostic score and to discuss its possible clinical implications. 
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Materials and Methods 
Patients and Data Collection 
A large set of more than 150 single items covering preoperative, operative, and postoperative 
data of every patient undergoing pancreatic surgery at the Department of Visceral Surgery, 
University Hospital of Lausanne (CHUV) is recorded in an electronic database (5, 13). Since 
2009, patient data are collected prospectively, whereas patients operated from 2000 to 2008 
have been entered retrospectively.  
This current study included only patients who underwent elective pancreatic head resection 
(pancreaticoduodenectomy (PD), Whipple’s procedure) for various benign and malignant 
diseases from 2000 to 2012. There were 256 patients identified as study patients, but 11 
patients were excluded due to incomplete data or other concomitant surgeries in addition to 
PD. Of note, 52.7% of all pancreas resections have been performed since 2009. 
The study was approved by the local Ethics Committee. 
Surgical techniques 
Most PDs (n=210) have been performed as so-called “classic” pancreatic head resection. 
Briefly, the pancreatic head was resected en-bloc together with the duodenum, the distal 
common bile duct, as well as the distal stomach. In addition, the resection included the first 
jejunal loop, the gallbladder, and loco-regional lymph nodes (14). A pylorus-preserving PD 
was preferentially used for benign disease (15, 16). The standard reconstruction of the 
alimentary tract included a pancreatico-enteric drainage, a bilio-enteric drainage, and finally a 
gastro-enteric anastomosis. In some few cases, a pancreaticogastrostomy was performed by a 
single surgeon who preferred this technique in case of soft pancreas. Two drains were 
routinely inserted near the pancreatico-enteric and bilio-enteric reconstructions. Drains were 
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removed on postoperative day 3 and 5, if there was no suspicion of leakage. Single-shot 
antibiotics were routinely used. 
Pancreatic texture was intraoperatively determined by the responsible surgeon and classified 
as soft or hard. Pancreatic duct diameter was also assessed intraoperatively.  
Assessment of postoperative morbidity and mortality 
Postoperative morbidity and mortality rates were defined as any adverse events during the 
first 30 days postoperatively or during hospitalization following pancreatic head resection. 
Complications were reported as number of complications, i.e., more than one complication 
per patient was possible. If appropriate, the highest classified complication was used for final 
analysis. Complications were graded according to their severity on a validated 5-point scale 
ranging from grade I to grade V (4, 17). Minor complications were defined as complications 
grade I and II, whereas major complications included complications grade IIIa to V. Of note, 
patient’s death was considered as lethal complication grade V. 
Specific definitions for surgical complications were used as they could be assessed according 
to internationally accepted guidelines (7–9). Pancreatic fistula: any measurable volume of 
fluid from a drain on or after postoperative day 3 with an amylase level greater than 3 times 
the serum amylase activity (7); delayed gastric emptying: inability to return to a standard diet 
by the end of the first postoperative week or prolonged (!4 days) nasogastric intubation (8); 
hemorrhage: blood loss from drain or nasogastric tube, transfusion !3 units of packed red 
blood cells, or need for invasive treatment (9). Other postoperative complications collected 
were intra-abdominal infection (fluid or abscess), wound infection, bile leak, gastric leak, 
small bowel obstruction, portal vein thrombosis, cholangitis, and medical complications.  
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Assessment of complications was primarily performed by the surgical residents. Before 
entering complications into the database, all charts were reviewed by a single staff surgeon 
experienced in pancreatic surgery. 
Predictive score of major postoperative complications by Braga et al. (12) (Table 1) 
This score developed by Braga and colleagues was published in Annals of Surgery in 2011. It 
aims to predict the patient probability of having major postoperative complications after PD 
without regard to pathologies. Major complications were defined as complications IIIa to V 
according to Dindo-Clavien classification. After univariate and multivariate analyses four 
significant predictive factors were found: ASA score (I to III), pancreas texture (soft/hard), 
pancreatic duct diameter (> or "3mm), and blood loss during operation (! or <700ml). For 
each item between 0 and 6 risk points were attributed. Hence, the total score for an individual 
patient can range from 0 to 15 points. Each score level is related to a certain risk of 
developing major complications. A higher score should be associated with increased 
complication risk. For practical reasons, four risk categories have been defined. 
For each patient, an individual risk score was calculated to estimate the risk for postoperative 
complications. All these risk scores were put together to get the four risk categories of the 
Braga score. The major complication risk of our series was compared to the Braga cohort. 
Statistical analysis 
Continuous variables were compared and analyzed using a Mann-Whitney U-test, as the 
distribution was not Gaussian. Discrete variables (categorical distribution) were interpreted 
using a Pearson chi-square test. A p-value <0.05 was considered significant.  
The expected and observed numbers of patients of the different outcome categories were 
compared, and calibration was tested for a possible significance by using Hosmer-Lemeshow 
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goodness-of-fit statistic. In order to assess the discriminant power of the score, ROC curves 
were calculated (C-statistic index). 
All statistical analyses were performed by using GraphPad Prism 5 for Mac OS X (GraphPad 
Software Inc.).  
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Results 
Patients’ characteristics and intraoperative findings  
There were 147 men and 98 women with a median age of 65 years (interquartile range 54 to 
75 years) who represent the study cohort. Table 2 summarizes patients’ characteristics and 
intraoperative findings. 
Operative indications were ductal adenocarcinomas (122 patients, 49.8%), ampullary cancers 
(35 patients, 14.5%), cholangiocarcinomas (12 patients, 4.8%), neuroendocrine tumors (9 
patients, 3.6%), intraductal papillary mucinous neoplasms (7 patients, 2.8%), benign lesions 
(37 patients, 15.1%), and chronic pancreatitis (23 patients, 9.4%). Among the 37 patients with 
benign lesions, 7 had mucinous cystadenomas, 6 serous cystadenomas, 5 pseudocysts, 4 
papillary adenomas, 4 choledochal adenomas, 3 familial polyposis, 3 lymphoepithelial cysts, 
2 pancreatic intraepithelial neoplasias, 1 solid pseudopapillary tumor, 1 inflammatory 
choledochal lesion, and 1 no abnormality (normal tissue). 
Median blood loss in the overall, minor complication, and major complication groups were 
400 ml, 400 ml, and 500 ml, respectively. By classifying the amount of blood loss according 
to the Braga score (!700ml vs <700ml), blood loss was significantly correlated with the 
occurrence of major complications (p=0.02). By classifying pancreatic texture according to 
the Braga score (soft vs hard), patients with major complications had significantly softer 
pancreas (p<0.01). 
Postoperative complications and length of hospital stay (Table 3) 
The overall complication rate was 68.6%, indicating that 168 out of 245 patients had at least 
one complication. While minor complications occurred in 93 patients (38%), major 
complications were observed in 75 patients (30.6%). The highest ranked complication was 
grade I in 29 patients (11.8%), grade II in 64 patients (26.1%), grade IIIa in 22 patients (9%), 
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grade IIIb in 18 patients (7.3%), grade IVa in 12 patients (4.9%), grade IVb in 13 patients 
(5.3%), and grade V in 10 patients (4.1%), respectively. 
Specific complications related to pancreatic resection, in particular, pancreatic fistula, delayed 
gastric emptying, and bleeding occurred in 47 (16.2%), 58 (19.9%), and 27 (9.3%) cases, 
respectively. Surgery-related infectious complications, such as wound infections and intra-
abdominal abscess formation were observed in 52 (17.9%) and 35 (12%) cases. Non-surgical 
infections, e.g., urinary tract infections, cholangitis, or pancreatitis occurred in <3% each. 
Length of hospital stay was correlated to the occurrence of major complications. The overall 
median length of stay for all patients was 18 days (interquartile range 13 to 27 days), but in 
case of major complications, the median hospital stay was significantly prolonged to 29 days 
(interquartile range 20 to 44 days).  
Braga risk prediction score (Figures 1, 2, and 3) 
For each patient, an individual risk score and its predicted risk were calculated. Thereby, the 
predicted mean risk for major complications in the overall group was 15.6% (38 patients out 
of 245 patients). The effectively observed rate was 30.6% (75 patients out of 245 patients). 
Patients with major complications (75 out of 245 patients) had a mean risk score of 8 points, 
meaning 18.4% risk for major complications. 
The predictive performance of the Braga score in our patient cohort, using the four risk 
categories is shown in Figure 1. Compared to the Braga paper, our effective major 
complication risks are 2-3-fold increased in each of the four risk groups.    
Predicted and observed mean risks for major complications were similar for all four risk 
categories and for progressive values, respectively (p=0.68 and p=0.82, Hosmer-Lemeshow 
test). ROC curves (four risk groups and progressive values) were calculated to determine the 
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discriminant power of the score. C-statistic index was 0.95 for four risk groups and 0.99 for 
progressive values (Figure 2 and 3). 
Subgroup analysis 
A subgroup analysis of all patients operated since 2009 and collected prospectively (n=130) 
was performed. Major complications occurred in 36.9% of the patients (48 patients). ROC 
curve for score categorized in four risk groups showed a C-statistic index of 0.956 
(p<0.0001). ROC curve for score in progressive values showed a C-statistic index of 0.994 
(p<0.0001). 
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Discussion 
To decrease morbidity rates has come to the fore in pancreas surgery since there is good 
evidence that postoperative complications are associated with multiple negative 
consequences. This current study aimed to validate a recently published risk prediction score 
for major postoperative complications in a large single-center series of pancreatic head 
resections. Despite the fact that the major complication rate was 2-fold higher in our series 
compared to Braga’s original series (31% vs 17%), the discriminant power of the score was 
preserved, and it can be considered as a potentially valuable adjunct tool to early identify 
patients at risk.     
Braga et al. developed their score aiming to identify patients at risk for all types of major 
complications after pancreaticoduodenectomy, while other groups only focused their attempts 
on the prediction of pancreas-specific complications, e.g., pancreatic fistula (18–21). This 
latter aspect considers predominantly the surgeon’s perspective on complications specifically 
related to pancreas surgery, but from a patient’s perspective, the general occurrence, the 
severity of complications, and its consequences are much more relevant.  
Whether predictive scores are really used in daily clinical practice is mainly dependent on 
their applicability, their robustness to reliably predict adverse events, and finally if effective 
prophylactic and therapeutic interventions are available to improve individual patient’s 
outcome. A basic prerequisite is furthermore an external validation performed in other 
institutions using independent patient groups. The Braga score fulfills several of the above 
mentioned criteria. The application is easy as the score is only based on four criteria, all of 
which are pre- or intraoperatively already available. Hence, there is time to react if considered 
necessary, e.g., to adapt the type of reconstruction, to insert drains, to use feeding tubes, as 
well as a closer postoperative surveillance with prolonged ICU stay, to perform early 
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imaging, or reinterventions. However, the score has never been externally validated until now, 
and it remains unclear, whether risk prediction is feasible and reliable in other patient groups 
after pancreas resection and other surgical institutions. 
Compared to other predictive scores like the PREPARE score that are based only on 
preoperative items, the Braga score includes intraoperative parameters which precludes 
undertaking preventive measures before the operation (22). Nevertheless, the Braga score is 
easy to calculate and allows a clinical estimation of the postoperative risk for complications. 
The Braga score offers therefore additional insights and can be complementary to other 
preoperative risk scores like the PREPARE score. 
The overall complication rates of our series and the Braga series were similar with 68.6% and 
61.7%, respectively (12). However, the overall severe complication rates were very different 
with 30.6% in our series compared to only 16.7% in the Braga series. While the mortality 
rates (grade V complications) were within the same range (4.1% our series vs. 3.9% Braga 
series), we had an important general tendency to a higher rating of all complications, in 
particular complications grade III and IV. This finding is in line with the fact that we 
observed fewer complications grade I (11.8% vs. 16.4%) and had a lower rate of patients 
without complications (31.4% vs. 38.2%).  
Another important issue is the correct assessment of complications. In this context, it is not 
known who performed the assessment of complications in the Braga series. One single staff 
surgeon was responsible for the correct assessment in our series (23). Of note, a potential bias 
in our and the Braga patient group may be that the grading of complications has been 
performed retrospectively in some early operated patients as the Dindo-Clavien complication 
classification has only been published in 2004 (17).  
Regarding the types of complications, our series had increased rates of infectious 
complications, as wound infections, intra-abdominal abscess formation, as well as pneumonia. 
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In contrast, intraperitoneal bleeding, pancreas-specific complications, i.e., pancreatic fistula 
and delayed gastric emptying occurred less frequently. 
The predicted major complication rate in our series was 15.6% using the risk prediction score, 
but the observed effective rate was 30.8%. This underestimation is in contrast to the findings 
of the Braga group, where predicted and effectively observed major complication rates were 
very close. It can be concluded that our patient group (validation group) and the original 
patient group of Braga et al, revealed similar characteristics as predicted major complication 
rates were comparable. Observed discrepancies may be related to the tendency to “overrate” 
complications in our series as complications are recorded prospectively as soon as they 
occurred clinically. In addition, the management of complications varies between institutions, 
e.g., a more aggressive approach to treat complications automatically increases the grading. 
Thus, single institutions may have to adjust the score to their overall and major complication 
rates. Presumably the score may need further adaptations if novel techniques for complication 
management develop.    
ROC curves confirmed the discriminant power of the score in our patient group. This means 
that the somewhat subjective grading of complications is not a confounding factor impairing 
the robustness of Braga score. The Braga score offers reliable and reproducible risk 
estimation for major postoperative complications in different patient populations (24, 25). Its 
criteria represent known risk factors in pancreatic surgery. The ASA classification is a 
surrogate parameter estimating pre-existing comorbidities, such as cardiovascular disease that 
is known to increase postoperative morbidity (26). As already published and confirmed also 
in this series, pancreas texture represents an important prognostic factor of major 
complications (10). The pancreatic duct diameter is a surrogate for the degree of technical 
difficulty to perform a safe entero-pancreatic anastomosis. Blood loss can be considered as 
parameter for the magnitude of the operative trauma.  
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In conclusion, the Braga risk prediction score represents an interesting tool for clinicians to 
potentially influence postoperative outcome after pancreas head resections. Further 
exploration by using a predefined risk score and therapeutic interventions is worthwhile.   
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Table 1. Braga risk score (adapted from reference 12) 
 
Predictor Categories  Risk score 
Pancreatic texture Hard  
Soft  
0 
4 
Main pancreatic duct diameter >3mm 
"3mm 
0 
1 
Operative blood loss <700ml 
!700ml 
0 
4 
ASA score I 
II 
III/IV 
0 
2 
6 
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Table 2. Patients’ characteristics and intraoperative findings1 
   
All 
patients  
Grade  
0-II  
Grade 
III-V  P-value 
   n=245  n=172  n=73   
                  
 
Age (yrs)  65 54-75 64 54-74 67 53-76 0.34 
Gender        0.48 
 Men 147 60.0% 106 61.6% 41 56.2%  
 Women 98 40.0% 66 38.4% 32 43.8%  
BMI (kg/m2)  24.1 21.6-26.5 24.2 21.6-26.6 23.6 21.6-26.2 0.74 
ASA        0.27 
 I 15 6.1% 12 7.0% 3 4.1%  
 II 166 67.8% 120 69.8% 46 63.0%  
 III 62 25.3% 39 22.7% 23 31.5%  
 IV 2 0.8% 1 0.6% 1 1.4%  
Operative indication for 
malignant disease 169 69.0% 112 65.1% 57 78.1% 0.45 
Blood loss (ml)  400 300-800 400 300-700 500 400-800 0.01 
Blood loss      !  0.02 
 <700ml 183 74.7% 136 79.1% "#! 64.4%  
 !700ml 62 25.3% 36 20.9% $%! 35.6%  
Pancreatic texture     !  <0.01 
 Soft 94 38.4% 49 28.5% "&! 61.6%  
 Hard 151 61.6% 123 71.5% $'! 38.4%  
Main pancreatic duct 
diameter     !  0.12 
 "3mm 138 56.3% 91 52.9% "#! 64.4%  
 >3mm 107 43.7% 81 47.1% $%! 35.6%  
Pancreatic anastomosis     !  0.39 
 PJ 145 59.2% 105 61.0% "(! 54.8%  
 PG 100 40.8% 67 39.0% ))! 45.2%  
 
1Data are number of patients (with percentage) or median (with interquartile range). !
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Table 3. Postoperative complications and length of hospital stay 
    
All patients 
(245)   Grade 0-II Grade III-V P-value 
        
Absence of complications 77 31.4% 77 (31.4%)   
Dindo-Clavien classification1       
 I 29 11.8% 29 (11.8%)   
 II 64 26.1% 64 (26.1%)   
 IIIa 22 9.0%  22 (9.0%)  
 IIIb 18 7.3%  18 (7.3%)  
 IVa 12 4.9%  12 (4.9%)  
 IVb 13 5.3%  13 (5.3%)  
 V 10 4.1%  10 (4.1%)  
Number of complications 291     
Pancreatic fistula 47 16.2%    
Delayed gastric emptying 58 19.9%    
Wound infection 52 17.9%    
Abdominal abscess 35 12.0%    
Bile leak  12 4.1%    
Intraperitoneal bleeding 27 9.3%    
Ileus  6 2.1%    
Pneumonia  15 5.2%  ¨  
Urinary tract infection  4 1.4%    
Atrial fibrillation 4 1.4%    
Respiratory failure 3 1.0%    
Cholangitis  8 2.7%    
Acute pancreatitis 2 0.7%    
Myocardial infarction  3 1.0%    
Pulmonary embolism 5 1.7%    
Acute renal failure 5 1.7%    
Other medical complications 5 1.7%    
Length of hospital stay (days)2 18 (13-27)  15 (11-20) 29 (20-44) <0.001 !
1 !"#$"%&"#'($)*+,#-$./012%.*(%/+$1#)$1*(%#+($3*'$%+.24-#-5 
2 Median with interquartile range. 
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Figure 1. Risk prediction of major complication rate using four risk classes of the score 
Figure 2. ROC curve for score categorized in four risk groups (C-statistic index: 0.9494, 
P<0.0001, 95% confidence interval: 0.933 to 0.966) 
Figure 3. ROC curve for score in progressive values (C-statistic index: 0.992, P<0.0001, 95% 
confidence interval: 0.983 to 1) 
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